NGF   Click here for help

GtoPdb Ligand ID: 5026

Synonyms: beta-nerve growth factor | beta-NGF | Oxervate® | Sentinel®
Approved drug
NGF is an approved drug (EMA (2017), FDA (2018))
Comment: Recombinant NGF (cenegermin, also known as cenegermin-bkbj) is used clinically as a peripherally selective agonist of TrkA and LNGFR. Note that the recombinant peptide is two amino acids shorter than the endogenous peptide, with the carboxy-terminal RA (Arg-Ala) removed.
Species: Human
Click here for help
Classification Click here for help
Compound class Endogenous peptide in human, mouse or rat
Approved drug? Yes. EMA (2017)  |  FDA (2018)
International Nonproprietary Names Click here for help
INN number INN
10381 cenegermin
Synonyms Click here for help
beta-nerve growth factor | beta-NGF | Oxervate® | Sentinel®
Gene/Precursor Click here for help
Gene symbol Gene name Species Precursor protein name Synonyms
NGF nerve growth factor Human prepro-beta-nerve growth factor nerve growth factor (beta polypeptide), NGFB
Database Links Click here for help
CATH/Gene3D 2.10.90.10
Ensembl Gene ENSG00000134259 (Hs)
GtoPdb PubChem SID 178101723
Human Protein Atlas ENSG00000134259 (Hs)
Search PubMed clinical trials cenegermin
Search PubMed titles cenegermin
Search PubMed titles/abstracts cenegermin
UniProtKB P01138 (Hs)
Wikipedia Nerve_growth_factor